Viewing register:

PPB

Marketing Authorisation Holder

HETERO BIOPHARMA LIMITED.

FOREIGN

7

Total Medicines

7

Active

7

Dosage Forms

1

Country

Kenya (7)

Registration Status

Registered 7

Dosage Forms

BEVACIZUMAB 400MG/16ML 1 500MG/50ML 1 440 MG / VIAL 1 40 MCG/0.40 ML 1 25 MCG/0.42 ML 1 150MG/15ML 1 100MG/10ML 1

Therapeutic Classes

GENERIC/BIOSIMILARS 7

Local Agents / Applicants

HETERO BIOPHARMA LIMITED. 7

Registered Medicines

Showing 7 of 7

Product	Form / Strength	Country	Reg. Number	Status
BEVAAS 400 BEVACIZUMAB	BEVACIZUMAB 400MG/16ML	Kenya	H2020/CTD7970/15215	Registered
DERISE 25 DARBEPOETIN ALFA	25 MCG/0.42 ML	Kenya	H2019/CTD5182/1062ER	Registered
DERISE 40 DARBEPOETIN ALFA	40 MCG/0.40 ML	Kenya	H2019/CTD6005/1063ER	Registered
RILAST 100 RITUXIMAB	100MG/10ML	Kenya	H2019/CTD5180/1064ER	Registered
RILAST 500 RITUXIMAB	500MG/50ML	Kenya	H2019/CTD5181/1065ER	Registered
TRASTUZUMAB 150MG / VIAL TRASTUZUMAB	150MG/15ML	Kenya	H2022/CTD10747/23854	Registered
TRASTUZUMAB 440MG / VIAL TRASTUZUMAB	440 MG / VIAL	Kenya	H2022/CTD10748/23871	Registered